A Lysozyme Concentration, pH, and Time-Dependent Isothermal Transformation Diagram Reveals Fibrous Amyloid and Non-Fibrous, Amorphous Aggregate Species

DOI: 10.4236/ojbiphy.2014.42006   PDF   HTML   XML   4,637 Downloads   7,162 Views   Citations


Deposition of aggregated protein is associated with many human diseases. The mechanism by which protein aggregate species cause cellular death remains unclear. A profile revealing protein aggregation products under a diverse set of conditions allows the search of novel aggregate products and potential pathogens. To achieve this end, an isothermal transformation diagram (ITD) of lysozyme aggregation was constructed. AFM, TEM, and Thioflavin T binding assays were used to analyze the aggregate species synthesized under a broad range of pH values, protein concentrations, and incubation times. Four states were found: 1) soluble protein species; 2) insoluble amyloid fibers; 3) insoluble amorphous aggregates; and 4) protein hydrogels. The hydrogel-a rises from aggregated amyloid fibers. This work is part of an effort to construct an array of ITDs reporting aggregation properties of many disease relevant proteins, including amyloid beta, tau, α-synuclein, and others involved in protein aggregation diseases. In addition, we propose hydrogel cyto toxicity as a potential novel mechanism in the pathogenesis of amyloid diseases.

Share and Cite:

Burnett, L. , Burnett, B. , Li, B. , Durrance, S. and Xu, S. (2014) A Lysozyme Concentration, pH, and Time-Dependent Isothermal Transformation Diagram Reveals Fibrous Amyloid and Non-Fibrous, Amorphous Aggregate Species. Open Journal of Biophysics, 4, 39-50. doi: 10.4236/ojbiphy.2014.42006.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Xu, S. (2007) Aggregation Drives “Misfolding” in Protein Amyloid Fiber Formation. The International Journal of Experimental and Clinical Investigation: The Official Journal of the International Society of Amyloidosis, 14, 119-131.
[2] Haataja, L., et al. (2008) Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis. Endocrine Reviews, 29, 303-316.
[3] Pepys, M., et al. (1993) Human Lysozyme Gene Mutations Cause Hereditary Systemic Amyloidosis. Nature, 362, 553-557.
[4] Yazaki, M., Farrell, S. and Benson, M. (2003) A Novel Lysozyme Mutation Phe57Ile Associated with Hereditary Renal Amyloidosis. Kidney International, 63, 1652-1657.
[5] Granel, B., et al. (2006) Lysozyme Amyloidosis: Report of 4 Cases and a Review of the Literature. Medicine, 85, 66-73.
[6] Straub, J. and Thirumalai, D. (2011) Toward a Molecular Theory of Early and Late Events in Monomer to Amyloid Fibril Formation. Annual Review of Physical Chemistry, 62, 437-463.
[7] Chiti, F. and Dobson, C. (2006) Protein Misfolding, Functional Amyloid, and Human Disease. Annual Review of Biochemistry, 75, 333-366.
[8] Nilsson, M.R. (2004) Techniques to Study Amyloid Fibril Formation in Vitro. Methods, 34, 151-160. http://dx.doi.org/10.1016/j.ymeth.2004.03.012
[9] Collins, S.D., Douglass, A., Vale, R.D. and Weissman, J.S. (2004) Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition. PLOS Biology, 321, 1582-1590.
[10] Kelly, J.W. (1998) The Alternative Conformations of Amyloidogenic Proteins Andtheir Multi-Step Assembly Pathways. Current Opinion in Structural Biology, 8, 101-106.
[11] Necula, M., et al. (2007) Small Molecule Inhibitors of Aggregation Indicate that Amyloid Beta Oligomerization and Fibrillization Pathways Are Independent and Distinct. The Journal of Biological Chemistry, 282, 10311-10324.
[12] Baskakov, I.B. and Olga, V. (2005) In Vitro Conversion of Mammalian Prion Protein into Amyloid Fibrils Displays Unusual Features. Biochemistry, 44, 2339-2348.
[13] Xu, S., Bevis, B. and Amsdorf, M. (2001) The Assembly of Amyloidogenic Yeast Sup35 as Assessed by Scanning (Atomic) Force Microscopy: An Analogy to Linear Colloidal Aggregation? Biophysical Journal, 81, 446-454.
[14] Xu, S. and Lin, B. (2001) The Mechanism of Oxidation-Induced Low-Density Lipoprotein Aggregation: An Analogy to Colloidal Aggregation and Beyond? Biophysical Journal, 81, 2403-2413.
[15] Rangachari, V., et al. (2006) Secondary Structure and Interfacial Aggregation of Amyloid-Beta (1-40) on Sodium Dodecyl Sulfate Micelles. Biochemistry, 45, 8639-8648.
[16] Qin, Z., et al. (2007) Structural Characterization of the Partially Folded Intermediates of an Immunoglobulin Light Chain Leading to Amyloid Fibrillization and Amorphous Aggregation. Biochemistry, 46, 3521-3531.
[17] Cheon, M., et al. (2007) Structural Reorganisation and Potential Toxicity of Oligomeric Species Formed during the Assembly of Amyloid Fibrils. PLoS Computational Biology, 3, 1727-1238. http://dx.doi.org/10.1371/journal.pcbi.0030173
[18] Walsh, D., et al. (2002) Naturally Secreted Oligomers of Amyloid-Beta Protein Potently Inhibit Hippocampal Long-Term Potentiation in Vivo. Nature, 416, 535-539.
[19] Anfinsen, C.B. (1972) The Formation and Stabilization of Protein Structure. Biochemical Journal, 128, 737-749.
[20] de la Torre, J.C. (2000) Cerebral Hypoperfusion, Capillary Degeneation, and Development of Alzheimer Disease. Alzheimer Disease and Associated Disorders, 14, 72-81.
[21] Uversky, V. and Fink, A. (2007) Protein Misfolding, Aggregation, and Conformational Diseases. In: Atassi, M.Z., Ed., Protein Reviews, Vol. 6, Springer, Berlin, 189-192.
[22] Hoyer, W., et al. (2002) Dependence of α-Synuclein Aggregate Morphology on Solution Conditions. Journal of Molecular Biology, 322, 383-393.
[23] Stranks, S.D., et al. (2009) Model for Amorphous Aggregation Processes. Physical Review E: Statistical, Nonlinear, and Soft Matter Physics, 80, 051907.
[24] Stefani, M. and Dobson, C. (2003) Protein Aggregation and Aggregate Toxicity: New Insights into Protein Folding, Misfolding Diseases and Biological Evolution. Journal of Molecular Medicine, 81, 678-699. http://dx.doi.org/10.1007/s00109-003-0464-5
[25] Kidd, M. (1964) Alzheimer’s Disease—An Electron Microscopical Study. Brain, 87, 307-320. http://dx.doi.org/10.1093/brain/87.2.307
[26] Yagishita, S., et al. (1981) Reappraisal of the Fine Structure of Alzheimer’s Neurofibrillary Tangles. Acta Neuropathologica, 54, 239-246.
[27] Rangachari, V.R., Reed, D.K., Moore, B.D. and Rosenberry, T.L. (2006) Secondary Structure and Interfacial Aggregation of Amyloid-Beta (1-40) on Sodium Dodecyl Sulfate Micelles. Biochemistry, 45, 8639-8648.
[28] Papon, P., Leblond, L. and Meijer, P. (2002) The Physics of Phase Transitions: Concepts and Applications. 2nd Edition, In: Papon, P., Leblond, J. and Meijer, P.H.E., Eds., Advanced Texts in Physics, Springer, Berlin, 123-162, 185-209.
[29] Bolder, S., et al. (2007) Thioflavin T and Birefringence Assays to Determine the Conversion of Proteins into Fibils. Langmuir, 23, 4144-4147.
[30] Xu, S., et al. (2010) Characterization of Tau Fibrillization in Vitro. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 6, 110-117.
[31] Xu, S. and Arnsdorf, M. (1994) Calibration of the Scanning (Atomic) Force Microscope with Gold Particles. Journal of Microscopy, 173, 199-210.
[32] Rocken, C., et al. (2006) ALys Amyloidosis Caused by Compound Heterozygosity in Exon 2 (Thr70Asn) and Exon 4 (Trp112Arg) of the Lysozyme Gene. Human Mutation, 27, 119-120.
[33] Valleix, S., et al. (2002) Hereditary Renal Amyloidosis Caused by a New Variant Lysozyme W64R in a French Family. Kidney International, 61, 907-912.
[34] Swaminathan, R., et al. (2011) Lysozyme: A Model Protein for Amyloid Research. Advances in Protein Chemistry and Structural Biology, 84, 63-111.
[35] Cao, A., Hu, D. and Lai, L. (2004) Formation of Amyloid Fibrils from Fully Reduced Hen Egg White Lysozyme. Protein Science: A Publication of the Protein Society, 13, 319-324.
[36] Yonezawa, Y., et al. (2002) An Insight into the Pathway of the Amyloid Fibril Formation of Hen Egg White Lysozyme Obtained from a Small-Angle X-Ray and Neutron Scattering Study. Journal of Molecular Biology, 323, 237-251.
[37] Morozova-Roche, L.A., et al. (2000) Amyloid Fibril Formation and Seeding by Wild-Type Human Lysozyme and Its Disease-Related Mutational Variants. Journal of Structural Biology, 130, 339-351. http://dx.doi.org/10.1006/jsbi.2000.4264
[38] Barkholt, V. and Jensen, A. (1989) Amino Acid Analysis: Determination of Cystein Plus Half-Cystein in Proteins after Hydrochloric Acid Hydrolysis with a Disulfide Compound as Additive. Analytical Biochemistry, 177, 318-322.
[39] Hoare, D. and Koshland Jr., D.A. (1967) Method for the Quantitative Modification and Estimation of Carboxylic Acid Groups in Proteins. The Journal of Biological Chemistry, 242, 2447-2453.
[40] Spencer, R. and Finn, W. (1969) A New Convenient Method for Estimation of Total Cysine-Cysteine in Proteins. Analytical Biochemistry, 32, 185-190.
[41] Bolisetty, S., et al. (2012) Gelation, Phase Behavior, and Dynamics of Beta-Lactoglobulin Amyloid Fibrils at Varying Concentrations and Ionic Strengths. Biomacromolecules, 13, 3241-3252. http://dx.doi.org/10.1021/bm301005w
[42] Pasternack, R., et al. (2006) Formation Kinetics of Insulin-Based Amyloid Gels and the Effect of Added Metalloporphyrins. Biophysical Journal, 90, 1033-1042.
[43] Krysmann, M.J., Castelletto, V., Kelarakis, A., Hamley, I.W., Hule, R.A. and Pochan, D.J. (2008) Self-Assembly and Hydrogelation of an Amyloid Peptide Fragment. Biochemistry, 47, 4597-4605. http://dx.doi.org/10.1021/bi8000616
[44] Bhak, G., et al. (2010) Amyloid Hydrogel Derived from Curly Protein Fibrils of Alpha-Synuclein. Biomaterials, 31, 5986-5995.
[45] Michael, R., et al. (2013) Absence of Beta-Amyloid in Cortical Cataracts of Donors with and without Alzheimer’s Disease. Experimental Eye Research, 106, 5-13.
[46] Serrano-Pozo, A., et al. (2011) Neuropathological Alterations in Alzheimer Disease. Cold Spring Harbor Perspectives in Medicine, 1, 006189.
[47] Atwood, C.S., Moir, R.D., Huang, X., Scarpa, R., Bacarra, M., Romano, D., Hartshorn, M., Tanzi, R. and Bush, A. (1998) Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis. The Journal of Biological Chemistry, 23, 12817-12826. http://dx.doi.org/10.1074/jbc.273.21.12817
[48] Castellani, R., et al. (2007) Iron: The Redox-Active Center of Oxidative Stress in Alzheimer Disease. Neurochemical Research, 32, 1640-1645.
[49] El-Agnaf, O., et al. (2001) Non-Fibrillar Oligomeric Species of the Amyloide ABri Peptide, Implicated in Familial British Dementia, Are More Potent at Inducing Apoptotic Cell Death than Protofibrils or Mature Fibrils. Journal of Molecular Biology, 310, 157-168.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.